Quickly sort and find the exact file you need here. Send the files directly into your Shareholder Briefcase or read and right click "save target as" individual files.
|Fact Sheet||372.4 KB|
|Charter of the Compensation Committee||154.3 KB|
|Charter of the Audit Committee||97.1 KB|
|Charter of the Nominating and Governance Committee||42.7 KB|
|Code of Business Conduct and Ethics||51.0 KB|
|Regulation FD Policy||133.1 KB|
|Whistle Blowing Policy||33.8 KB|
|2006 Annual Report||2006||1.0 MB|
|2006 Form 10-K||2006||616.2 KB|
|2005 Annual Report||2005||592.7 KB|
- Corporate Governance
- Management & Board
- Stock Information
- SEC Filings
- Quarterly Results
- Analyst Coverage
- Webcasts & Presentations
- Scientific Publications & Presentations
- Frequently Asked Questions
© 2004-2014 OncoGenex Pharmaceuticals Inc. All rights reserved.
OncoGenex product candidates are investigational drugs for use only in approved clinical trials.
OncoGenex Pharmaceuticals is a drug discovery and development company uniquely focused on the challenge of cancer treatment resistance.
OncoGenex is uniquely focused on the challenge of cancer treatment resistance. We currently have several on-going clinical trials that may be of interest to you.
OncoGenex focuses on diverse molecular entities that target mechanisms of resistance and that have the potential to re-define treatment paradigms in a variety of cancers.
OncoGenex develops novel compounds designed to meet the persistent challenge of treatment resistance across a variety of cancers.